A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. (4th November 2015)

Record Type:: Journal Article
Title:: A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors. (4th November 2015)
Main Title:: A Phase I study to evaluate the safety and antitumor activity of durvalumab (MEDI4736) in combination with tremelimumab in patients with advanced solid tumors
Authors:: Papadopoulos, Kyriakos P
Tsai, Frank
Hamid, Omid
Xiao, Feng
Steele, Keith E
Rebelatto, Marlon C
Robbins, Paul B
Karakunnel, Joyson J
Lai, Dominic W
Mahipal, Amit
Abstract:
Is Part Of:: Journal for immunotherapy of cancer. Volume 3(2015)Supplement 2
Journal:: Journal for immunotherapy of cancer
Issue:: Volume 3(2015)Supplement 2
Issue Display:: Volume 3, Issue 2 (2015)
Year:: 2015
Volume:: 3
Issue:: 2
Issue Sort Value:: 2015-0003-0002-0000
Page Start:
Page End:
Publication Date:: 2015-11-04
Subjects:: Antitumor Activity -- Tumor Infiltrate Lymphocyte -- Immune Checkpoint -- Advanced Solid Tumor -- Acceptable Safety Profile
Cancer -- Immunotherapy -- Periodicals
Cancer -- Immunological aspects -- Periodicals
Tumors -- Immunological aspects -- Periodicals
Immunotherapy -- Periodicals
616.99406105
Journal URLs:: http://www.immunotherapyofcancer.org ↗
https://jitc.bmj.com/ ↗
http://link.springer.com/ ↗
DOI:: 10.1186/2051-1426-3-S2-P165 ↗
Languages:: English
ISSNs:: 2051-1426
Deposit Type:: Legaldeposit
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗
Physical Locations:: British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store
Ingest File:: 19195.xml